机构:[1]Department of Urology and Pelvic Surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.[2]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.四川大学华西医院[3]Department of Urology and Pelvic Surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
第一作者机构:[1]Department of Urology and Pelvic Surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
通讯作者:
通讯机构:[3]Department of Urology and Pelvic Surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.[*1]Department of Urology and Pelvic surgery, West China School of Public Health and West China, Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
推荐引用方式(GB/T 7714):
Du Jie,Feng Dechao,Chen Guo.TANK binding kinase 1 (TBK1) could serve as a prognostic biomarker for kidney renal papillary cell carcinoma patients[J].Asian journal of surgery.2023,doi:10.1016/j.asjsur.2023.03.010.
APA:
Du Jie,Feng Dechao&Chen Guo.(2023).TANK binding kinase 1 (TBK1) could serve as a prognostic biomarker for kidney renal papillary cell carcinoma patients.Asian journal of surgery,,
MLA:
Du Jie,et al."TANK binding kinase 1 (TBK1) could serve as a prognostic biomarker for kidney renal papillary cell carcinoma patients".Asian journal of surgery .(2023)